OpenEvidence hits $12B valuation as specialized medical AI demand doubles in months
OpenEvidence has achieved a $12B valuation after a $250M Series D round. Learn how this medical AI platform for doctors doubled its value and surpassed $100M in revenue.
In just three months, its market value has doubled. Medical AI powerhouse OpenEvidence has reached a staggering $12 billion valuation, proving that Silicon Valley is placing its biggest bets on deep, vertical expertise rather than broad, general-purpose AI.
OpenEvidence hits $12B valuation via Series D milestone
According to TechCrunch, OpenEvidence announced on Wednesday that it's raised $250 million in a Series D funding round co-led by Thrive Capital and DST. This new injection of capital values the startup at $12 billion, a 100% jump from its $6 billion valuation in October 2025. The company has now raised a total of $700 million to date.
Surpassing $100M in revenue through clinician trust
While many AI startups struggle with monetization, OpenEvidence has already surpassed the $100 million revenue mark. Its platform served 18 million clinical consultations from verified U.S. healthcare professionals in December 2025 alone—a massive spike from the 3 million monthly searches recorded just a year prior.
Winning the healthcare AI war against giants
Investors don't seem worried about competition from OpenAI or Anthropic. OpenEvidence's laser focus on doctor-facing clinical information sets it apart from Anthropic's broader 'Claude for Healthcare' and ChatGPT's consumer-centric health products. The startup's ability to win over skeptical medical professionals gives it a moat that general models haven't yet breached.
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
University of Illinois researchers combined frying and microwave heating to reduce oil absorption in french fries — without sacrificing crunch. Here's the science, and what it could mean for the food industry.
EV startup Ever raises $31M to reimagine car retail with AI-native approach, challenging traditional dealership model with integrated digital-physical experience.
Newly released DOJ documents reveal Jeffrey Epstein's attempts to invest in Lucid Motors, Faraday Future, and Canoo through mysterious intermediary David Stern.
Sapiom raises $15M to build payment infrastructure for AI agents, enabling autonomous purchasing of APIs and services without human intervention.
University of Illinois researchers combined frying and microwave heating to reduce oil absorption in french fries — without sacrificing crunch. Here's the science, and what it could mean for the food industry.
EV startup Ever raises $31M to reimagine car retail with AI-native approach, challenging traditional dealership model with integrated digital-physical experience.
Newly released DOJ documents reveal Jeffrey Epstein's attempts to invest in Lucid Motors, Faraday Future, and Canoo through mysterious intermediary David Stern.
Sapiom raises $15M to build payment infrastructure for AI agents, enabling autonomous purchasing of APIs and services without human intervention.
Thoughts
Share your thoughts on this article
Sign in to join the conversation